Yes. I have a comment. If you think this stock can only reach .25-.35 if 3Dprintright is successful, I would say you're absolutely foolish for being in the company. If they can only garner a $100 million market cap with that software, then I'd say it's pretty much a flop.
That's a bit pessimistic wouldn't you say? I think we easily make .25-.50 by EOY with the right news.
If the idea generation, development, and commercialization continue, I don't think their is any specific ceiling over our heads. I would not be at all surprised by multiple dollars a couple of years from now.
The dilution of shares is what killed the run. Because of the high number of shares the market cap is a bit high for this stock. The fact is the volume has flattened and will remain that way until a strong catalyst occurs. Real news, not some bs MOU with another company. So my contention is that this stock will remain sideways for a while. Most investors are simply on the sidelines waiting and watching for the next run to begin and then they will jump in on the momentum. The question is when will that be. I believe this stock is still fairly undiscovered. Organovo continues to go up since the correction and Arcam has been killing it. Sigma should be following suit but people are just scared after the recent crash.
News 
Market Data 
Discover 
